pepmg_

Study summary · research use only

Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration

Study · human · Journal of controlled release : official journal of the Controlled Release Society · 2026 · DOI 10.1016/j.jconrel.2025.114521 · PMID 41371501

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study (in vitro experiments plus a rabbit fascia-defect model) developed a Golgi-targeted copper delivery system (LNP-ATOX1/GHK-Cu@PCL-GelMA), in which GHK-Cu supplies copper ions and lipid nanoparticles deliver mRNA encoding the copper chaperone ATOX1, intended to increase activity of copper-dependent proteins such as lysyl oxidase (LOX) via the Golgi apparatus and ATP7A/B. In vitro, the system increased copper accumulation in the Golgi apparatus, raised LOX activity to 1.78 times that of the control group, and was associated with increased angiogenic capacity. In the rabbit fascia defect model, the strategy was associated with collagen alignment, neovascularization, and extracellular matrix reconstruction consistent with fascia regeneration.

Abstract

Copper-dependent proteins (such as lysyl oxidase, LOX) require copper acquisition within the Golgi apparatus to achieve enzymatic activation, and insufficient activation of these proteins is a key factor limiting fascia regeneration. To address this issue, this study, for the first time, proposes and validates a Golgi-targeted copper delivery system (LNP-ATOX1/GHK-Cu@PCL-GelMA). In this system, GHK-Cu serves as a stable copper source to provide a sustained release of Cu ions for cellular uptake, while lipid nanoparticles (LNPs) are used to deliver mRNA encoding the copper chaperone ATOX1. Upregulation of ATOX1 facilitates the transport of copper into the Golgi apparatus via ATP7A/B, thereby enhancing the activity of copper-dependent proteins. In addition, ATOX1 promotes the copper-dependent translocation of ATP7A and Rac1 to the plasma membrane, synergistically accelerating neovascularization. In vitro studies demonstrated that this material system significantly increased copper accumulation within the Golgi apparatus, elevated LOX activity to 1.78 times that of the control group, and enhanced angiogenic capacity. In a rabbit fascia defect model, this strategy effectively promoted collagen alignment and neovascularization, improving extracellular matrix reconstruction and facilitating fascia regeneration. In conclusion, this work establishes a novel Golgi-targeted copper delivery strategy, providing a practical therapeutic approach for regenerative disorders caused by insufficient activation of copper-dependent proteins, such as fascia defects.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.